Alfuzosin is a selective alpha-1 adrenergic receptor antagonist primarily used to treat the symptoms of benign prostatic hyperplasia (BPH) by relaxing smooth muscle in the bladder neck and prostate. This… Read more








































Alfuzosin is a selective alpha-1 adrenergic receptor antagonist primarily used to treat the symptoms of benign prostatic hyperplasia (BPH) by relaxing smooth muscle in the bladder neck and prostate. This category contains the active pharmaceutical ingredient alongside a comprehensive range of reference standards, including pharmacopeial and non-pharmacopeial impurities, synthetic intermediates, and degradation products. These materials are essential for pharmaceutical laboratories conducting rigorous impurity profiling and stability testing to ensure regulatory compliance and therapeutic safety. Furthermore, stable isotope labelled compounds are available to provide precise internal standards for mass spectrometry-based quantification. By utilizing these high-quality reference materials, researchers can perform reliable analytical method validation and system suitability testing, ensuring accurate identification and control of related substances throughout the development and quality control of Alfuzosin formulations.